Olema Pharmaceuticals Inc.
OLMA | NASDAQ
$9.64
-$0.18 (-1.83%)
At close: Sep 21, 2026, 4:00 PM ET
$9.81
+$0.17 (+1.76%)
Pre-market:
Sep 22, 2026, 5:49 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 306K | 306K | 187K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -306K | -306K | -187K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -221.13M | -201.81M | -178.7M | -165.38M | -157.13M | -142.79M | -142.26M | -135.91M | -121.63M | -109.7M | -104.96M | -101.76M | -101.64M | -113.34M | -106.99M | -101.53M | -96.07M | -79.3M | -71.49M | -59.87M | -49.97M | -35.94M |
Interest Income | 16.94M | 16.48M | 16.22M | 15.51M | 14.79M | 13.85M | 12.68M | 12.94M | 11.93M | 10.37M | 8.33M | 5.75M | 4.45M | 3.32M | 2.23M | 1.36M | 847K | 549K | 442K | 334K | 252K | 168K |
Pretax Income | -204.57M | -185.15M | -162.45M | -149.96M | -142.3M | -128.89M | -129.47M | -122.68M | -109.63M | -99.34M | -96.66M | -96.06M | -97.28M | -110.04M | -104.79M | -100.25M | -95.24M | -78.79M | -71.1M | -59.59M | -49.72M | -35.77M |
Net Income | -204.57M | -185.15M | -162.45M | -149.96M | -142.3M | -128.89M | -129.47M | -122.68M | -109.63M | -99.34M | -96.66M | -96.06M | -97.28M | -110.04M | -104.79M | -100.25M | -95.24M | -78.79M | -71.1M | -59.59M | -49.72M | -35.77M |
Selling & General & Admin | 30.82M | 25.39M | 21M | 18.61M | 17.08M | 17.53M | 17.74M | 17.82M | 17.31M | 16.5M | 18.82M | 19.91M | 21.62M | 24.25M | 24.71M | 24.86M | 24.51M | 22.88M | 20.39M | 18.45M | 16.41M | 12.33M |
Research & Development | 190.19M | 176.31M | 157.7M | 146.78M | 140.05M | 125.26M | 124.52M | 118.09M | 104.32M | 93.2M | 86.14M | 81.85M | 80.03M | 89.09M | 82.27M | 76.67M | 71.56M | 56.42M | 51.1M | 41.41M | 33.56M | 23.6M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 220.82M | 201.51M | 178.51M | 165.38M | 157.13M | 142.79M | 142.26M | 135.91M | 121.63M | 109.7M | 104.96M | 101.76M | 101.64M | 113.34M | 106.99M | 101.53M | 96.07M | 79.3M | 71.49M | 59.87M | 49.97M | 35.94M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | -119K | -119K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 221.13M | 201.81M | 178.7M | 165.38M | 157.13M | 142.79M | 142.26M | 135.91M | 121.63M | 109.7M | 104.96M | 101.76M | 101.64M | 113.34M | 106.99M | 101.53M | 96.07M | 79.3M | 71.49M | 59.87M | 49.97M | 35.94M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 104.45M | 102.8M | 91.32M | 85.73M | 85.5M | 85.43M | 58.74M | 57.26M | 56.28M | 55.57M | 54.78M | 44.98M | 40.72M | 40.35M | 40.19M | 40.04M | 39.92M | 39.83M | 39.74M | 39.61M | 39.42M | 39.33M |
Shares Outstanding (Diluted) | 104.45M | 102.8M | 91.32M | 85.73M | 85.5M | 85.43M | 58.74M | 57.26M | 56.28M | 55.57M | 54.78M | 44.98M | 40.72M | 40.35M | 40.19M | 40.04M | 39.92M | 39.83M | 39.74M | 39.61M | 39.42M | 39.33M |
EPS (Basic) | -2.12 | -2.02 | -1.86 | -1.93 | -2.04 | -2.07 | -2.27 | -2.19 | -2.07 | -2.02 | -2.13 | -2.27 | -2.34 | -2.67 | -2.57 | -2.48 | -2.38 | -1.98 | -1.80 | -1.76 | -1.52 | -1.27 |
EPS (Diluted) | -2.13 | -2.03 | -1.87 | -1.93 | -2.04 | -2.07 | -2.27 | -2.19 | -2.07 | -2.02 | -2.13 | -2.27 | -2.34 | -2.67 | -2.57 | -2.48 | -2.38 | -1.98 | -1.80 | -1.76 | -1.52 | -1.27 |
EBITDA | -204M | -184.67M | -161.96M | -149.54M | -141.82M | -128.46M | -129.08M | -122.31M | -109.27M | -98.97M | -96.28M | -95.68M | -96.89M | -109.67M | -104.43M | -99.91M | -94.95M | -78.55M | -71.04M | -59.61M | -49.79M | -35.86M |
EBIT | -204.57M | -185.15M | -162.45M | -149.96M | -142.3M | -128.89M | -129.47M | -122.68M | -109.63M | -99.34M | -96.66M | -96.06M | -97.28M | -110.04M | -104.79M | -100.25M | -95.24M | -78.79M | -71.21M | -59.7M | -49.83M | -35.88M |
Depreciation & Amortization | 570K | 481K | 490K | 419K | 471K | 433K | 393K | 365K | 360K | 365K | 377K | 386K | 387K | 373K | 357K | 333K | 292K | 238K | 163K | 94K | 46K | 17K |
Add to Watchlist
Select watchlists to add or remove OLMA